The use of neuroproteomics in drug abuse research

Drug and Alcohol Dependence

Volumn 107, Issue 1, 2010, Pages 11-22

  Lull, Melinda E ^a   Freeman, Willard M ^a   VanGuilder, Heather D ^a   Vrana, Kent E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Bioinformatics; Drug abuse; Neuroproteomics; Proteome fractionation; Proteomics; Sample quality

Indexed keywords

ANIMAL BEHAVIOR; BIOTECHNOLOGY; CELL FRACTIONATION; CELL SELECTION; DATA ANALYSIS; DRUG ABUSE; DRUG ABUSE PATTERN; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; FLOW CYTOMETRY; FUNCTIONAL PROTEOMICS; GENOMICS; HUMAN; MASS SPECTROMETRY; MEDICAL RESEARCH; NEUROANATOMY; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTOMICS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MODELS, NEUROLOGICAL; PROTEOMICS; STATISTICS AS TOPIC; SUBSTANCE-RELATED DISORDERS; VALIDATION STUDIES AS TOPIC;

ANIMALIA;

EID: 74749085217     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.10.001     Document Type: Review

References (143)

1. Abul-Husn N.S., and Devi L.A. Neuroproteomics of the synapse and drug addiction. J. Pharmacol. Exp. Ther. 318 (2006) 461-468
2. Aebersold R. A stress test for mass spectrometry-based proteomics. Nat. Methods 6 (2009) 411-412
3. Al-Housseini A.M., Sivanandam T.M., Bradbury E.L., Tannenberg R.K., Dodd P.R., and Gu Q. Upregulation of beta-catenin levels in superior frontal cortex of chronic alcoholics. Alcohol Clin. Exp. Res. 32 (2008) 1080-1090
4. Allison D.B., Cui X., Page G.P., and Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 7 (2006) 55-65
5. Anderson L., and Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 5 (2006) 573-588
6. Anderson L., and Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18 (1997) 533-537
7. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25 (2000) 25-29
8. Barrett T., Troup D.B., Wilhite S.E., Ledoux P., Rudnev D., Evangelista C., Kim I.F., Soboleva A., Tomashevsky M., and Edgar R. NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res. 35 (2007) D760-D765
9. Barthelery M., Jaishankar A., Salli U., Freeman W.M., and Vrana K.E. 2D-DIGE indentification of differentially expressed HNRNPs and trancription factors during neural differentiation of human ES cells. Proteomics Clin. Appl. 3 (2009) 505-514
10. Bateup H.S., Svenningsson P., Kuroiwa M., Gong S., Nishi A., Heintz N., and Greengard P. Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat. Neurosci. 11 (2008) 932-939
11. Becker J.S., Becker J.S., Zoriy M.V., Dobrowolska J., and Matucsh A. Imaging mass spectrometry in biological tissues by laser ablation inductively coupled plasma mass spectrometry. Eur. J. Mass Spectrom. (Chichester, Eng) 13 (2007) 1-6
12. Bell A.W., Deutsch E.W., Au C.E., Kearney R.E., Beavis R., Sechi S., Nilsson T., Bergeron J.J., Beardslee T.A., Chappell T., Meredith G., Sheffield P., Gray P., Hajivandi M., Pope M., Predki P., Kullolli M., Hincapie M., Hancock W.S., Jia W., Song L., Li L., Wei J., Yang B., Wang J., Ying W., Zhang Y., Cai Y., Qian X., He F., Meyer H.E., Stephan C., Eisenacher M., Marcus K., Langenfeld E., May C., Carr S.A., Ahmad R., Zhu W., Smith J.W., Hanash S.M., Struthers J.J., Wang H., Zhang Q., An Y., Goldman R., Carlsohn E., van der P.S., Hung K.E., Sarracino D.A., Parker K., Krastins B., Kucherlapati R., Bourassa S., Poirier G.G., Kapp E., Patsiouras H., Moritz R., Simpson R., Houle B., Laboissiere S., Metalnikov P., Nguyen V., Pawson T., Wong C.C., Cociorva D., Yates Jr. I., Ellison M.J., Lopez-Campistrous A., Semchuk P., Wang Y., Ping P., Elia G., Dunn M.J., Wynne K., Walker A.K., Strahler J.R., Andrews P.C., Hood B.L., Bigbee W.L., Conrads T.P., Smith D., Borchers C.H., Lajoie G.A., Bendall S.C., Speicher K.D., Speicher D.W., Fujimoto M., Nakamura K., Paik Y.K., Cho S.Y., Kwon M.S., Lee H.J., Jeong S.K., Chung A.S., Miller C.A., Grimm R., Williams K., Dorschel C., Falkner J.A., Martens L., and Vizcaino J.A. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat. Methods 6 (2009) 423-430
13. Calu D.J., Stalnaker T.A., Franz T.M., Singh T., Shaham Y., and Schoenbaum G. Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in rats. Learn Mem. 14 (2007) 325-328
14. Caprioli R.M., Farmer T.B., and Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 69 (1997) 4751-4760
15. Che F.Y., Lim J., Pan H., Biswas R., and Fricker L.D. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol. Cell. Proteomics 4 (2005) 1391-1405
16. Chen P., Li X., Sun Y., Liu Z., Cao R., He Q., Wang M., Xiong J., Xie J., Wang X., and Liang S. Proteomic analysis of rat hippocampal plasma membrane: characterization of potential neuronal-specific plasma membrane proteins. J. Neurochem. 98 (2006) 1126-1140
17. Chen X., Sun L., Yu Y., Xue Y., and Yang P. Amino acid-coded tagging approaches in quantitative proteomics. Expert Rev. Proteomics 4 (2007) 25-37
18. Chin M.H., Geng A.B., Khan A.H., Qian W.J., Petyuk V.A., Boline J., Levy S., Toga A.W., Smith R.D., Leahy R.M., and Smith D.J. A genome-scale map of expression for a mouse brain section obtained using voxelation. Physiol. Genomics 30 (2007) 313-321
19. Chin M.H., Qian W.J., Wang H., Petyuk V.A., Bloom J.S., Sforza D.M., Lacan G., Liu D., Khan A.H., Cantor R.M., Bigelow D.J., Melega W.P., Camp D.G., Smith R.D., and Smith D.J. Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease. J. Proteome Res. 7 (2008) 666-677
20. Collins M.O., Yu L., Campuzano I., Grant S.G., and Choudhary J.S. Phosphoproteomic analysis of the mouse brain cytosol reveals a predominance of protein phosphorylation in regions of intrinsic sequence disorder. Mol. Cell. Proteomics 7 (2008) 1331-1348
21. Cornish J.L., and Kalivas P.W. Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge. Behav. Brain Res. 126 (2001) 205-209
22. Covarrubias M.Y., Khan R.L., Vadigepalli R., Hoek J.B., and Schwaber J.S. Chronic alcohol exposure alters transcription broadly in a key integrative brain nucleus for homeostasis: the nucleus tractus solitarius. Physiol. Genomics 24 (2005) 45-58
23. Cunha-Oliveira T., Rego A.C., and Oliveira C.R. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res. Rev. 58 (2008) 192-208
24. D'Ambrosio C., Arena S., Fulcoli G., Scheinfeld M.H., Zhou D., D'Adamio L., and Scaloni A. Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease. Mol. Cell. Proteomics 5 (2006) 97-113
25. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 (2003) 3
26. DeSouza L.V., Taylor A.M., Li W., Minkoff M.S., Romaschin A.D., Colgan T.J., and Siu K.W. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J. Proteome Res. 7 (2008) 3525-3534
27. Di C.P., Blaha C.D., and Phillips A.G. Changes in dopamine oxidation currents in the nucleus accumbens during unlimited-access self-administration of d-amphetamine by rats. Behav. Pharmacol. 7 (1996) 714-729
28. Di C.P., Blaha C.D., and Phillips A.G. The relation between dopamine oxidation currents in the nucleus accumbens and conditioned increases in motor activity in rats following repeated administration of d-amphetamine or cocaine. Eur. J. Neurosci. 10 (1998) 1113-1120
29. Dobretsova A., Johnson J.W., Jones R.C., Edmondson R.D., and Wight P.A. Proteomic analysis of nuclear factors binding to an intronic enhancer in the myelin proteolipid protein gene. J. Neurochem. 105 (2008) 1979-1995
30. Doyle J.P., Dougherty J.D., Heiman M., Schmidt E.F., Stevens T.R., Ma G., Bupp S., Shrestha P., Shah R.D., Doughty M.L., Gong S., Greengard P., and Heintz N. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135 (2008) 749-762
31. Dworkin S.I., Co C., and Smith J.E. Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res. 682 (1995) 116-126
32. Elkon R., Vesterman R., Amit N., Ulitsky I., Zohar I., Weisz M., Mass G., Orlev N., Sternberg G., Blekhman R., Assa J., Shiloh Y., and Shamir R. SPIKE-a database, visualization and analysis tool of cellular signaling pathways. BMC Bioinform. 9 (2008) 110
33. Epstein D.H., Preston K.L., Stewart J., and Shaham Y. Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 189 (2006) 1-16
34. Ersche K.D., Fletcher P.C., Roiser J.P., Fryer T.D., London M., Robbins T.W., and Sahakian B.J. Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers. Psychopharmacology (Berl) 188 (2006) 364-373
35. Eyerman D.J., and Yamamoto B.K. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J. Neurochem. 103 (2007) 1219-1227
36. Fan A.C., Deb-Basu D., Orban M.W., Gotlib J.R., Natkunam Y., O'Neill R., Padua R.A., Xu L., Taketa D., Shirer A.E., Beer S., Yee A.X., Voehringer D.W., and Felsher D.W. Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nat. Med. 15 (2009) 566-571
37. Finlay E.M., Games D.E., Startin J.R., and Gilbert J. Screening, confirmation, and quantification of sulphonamide residues in pig kidney by tandem mass spectrometry of crude extracts. Biomed. Environ. Mass Spectrom. 13 (1986) 633-639
38. Freeman W.M., Brebner K., Amara S.G., Reed M.S., Pohl J., and Phillips A.G. Distinct proteomic profiles of amphetamine self-administration transitional states. Pharmacogenomics J. 5 (2005) 203-214
39. Freeman W.M., Dougherty K.E., Vacca S.E., and Vrana K.E. An interactive database of cocaine-responsive gene expression. Sci. World J. 12 (2002) 701-706
40. Freeman W.M., Gooch R.S., Lull M.E., Worst T.J., Walker S.J., Xu A.S., Green H., Pierre P.J., Grant K.A., and Vrana K.E. Apo-AII is an elevated biomarker of chronic non-human primate ethanol self-administration. Alcohol Alcohol. 41 (2006) 300-305
41. Freeman W.M., and Hemby S.E. Proteomics for protein expression profiling in neuroscience. Neurochem. Res. 29 (2004) 1065-1081
42. Freeman W.M., and Vrana K.E. In: Madras B.K., Rutter J.L., Colvis C.M., Shurtleff J.D., et al. (Eds). Quantitative functionalgenomics and proteomics of drug abuse (2006), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 433-456
43. Gao X., and Chen J. Direct isolation of neural stem cells in the adult hippocampus after traumatic brain injury. J. Neurotrauma 25 (2008) 985-995
44. Garzon J., Rodriguez-Diaz M., Lopez-Fando A., Garcia-Espana A., and Sanchez-Blazquez P. Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain. Neuropharmacology 42 (2002) 813-828
45. Gawin F.H., and Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch. Gen. Psychiatry 43 (1986) 107-113
46. Gerber S.A., Rush J., Stemman O., Kirschner M.W., and Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6940-6945
47. Graziella D., Montis M., Co C., Dworkin S.I., and Smith J.E. Modifications of dopamine D1 receptor complex in rats self-administering cocaine. Eur. J. Pharmacol. 362 (1998) 9-15
48. Grimm J.W., Hope B.T., Wise R.A., and Shaham Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412 (2001) 141-142
49. Guevara R., Santandreu F.M., Valle A., Gianotti M., Oliver J., and Roca P. Sex-dependent differences in aged rat brain mitochondrial function and oxidative stress. Free Radic. Biol. Med. 46 (2008) 169-175
50. Hale E.A., Raza S.K., Ciecierski R.G., and Ghosh P. Deleterious actions of chronic ethanol treatment on the glycosylation of rat brain clusterin. Brain Res. 785 (1998) 158-166
51. Han B.S., Iacovitti L., Katano T., Hattori N., Seol W., and Kim K.S. Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra. Neurosci. Lett. 442 (2008) 190-194
52. Hemby S.E. Assessment of genome and proteome profiles in cocaine abuse. Prog. Brain Res. 158 (2006) 173-195
53. Horth P., Miller C.A., Preckel T., and Wenz C. Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis. Mol. Cell. Proteomics 5 (2006) 1968-1974
54. Hsu F., Kent W.J., Clawson H., Kuhn R.M., Diekhans M., and Haussler D. The UCSC known genes. Bioinformatics 22 (2006) 1036-1046
55. Hu W., Saba L., Kechris K., Bhave S.V., Hoffman P.L., and Tabakoff B. Genomic insights into acute alcohol tolerance. J. Pharmacol. Exp. Ther. 326 (2008) 792-800
56. Hunsucker S.W., Solomon B., Gawryluk J., Geiger J.D., Vacano G.N., Duncan M.W., and Patterson D. Assessment of post-mortem-induced changes to the mouse brain proteome. J. Neurochem. 105 (2008) 725-737
57. Hynd M.R., Lewohl J.M., Scott H.L., and Dodd P.R. Biochemical and molecular studies using human autopsy brain tissue. J. Neurochem. 85 (2003) 543-562
58. Jacobs E.H., de Vries T.J., Smit A.B., and Schoffelmeer A.N. Gene transcripts selectively down-regulated in the shell of the nucleus accumbens long after heroin self-administration are up-regulated in the core independent of response contingency. FASEB J. 18 (2004) 200-202
59. Jaishankar A., Barthelery M., Freeman W.M., Salli U., Ritty T., and Vrana K. Human embryonic and mesenchymal stem cells express different nuclear proteomes. Stem Cells Dev. 18 (2008) 793-802
60. Jones P., Cote R.G., Cho S.Y., Klie S., Martens L., Quinn A.F., Thorneycroft D., and Hermjakob H. PRIDE: new developments and new datasets. Nucleic Acids Res. 36 (2008) D878-D883
61. Jones P., Cote R.G., Martens L., Quinn A.F., Taylor C.F., Derache W., Hermjakob H., and Apweiler R. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res. 34 (2006) D659-D663
62. Jovanovski D., Erb S., and Zakzanis K.K. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J. Clin. Exp. Neuropsychol. 27 (2005) 189-204
63. Jupiter D.C., and VanBuren V. A visual data mining tool that facilitates reconstruction of transcription regulatory networks. PLoS ONE 3 (2008) e1717
64. Kalivas P.W., Peters J., and Knackstedt L. Animal models and brain circuits in drug addiction. Mol. Interv. 6 (2006) 339-344
65. Kanehisa M., and Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (2000) 27-30
66. Karp N.A., and Lilley K.S. Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes. Proteomics 5 (2005) 3105-3115
67. Kashem M.A., Harper C., and Matsumoto I. Differential protein expression in the corpus callosum (genu) of human alcoholics. Neurochem. Int. 53 (2008) 1-11
68. Kashem M.A., James G., Harper C., Wilce P., and Matsumoto I. Differential protein expression in the corpus callosum (splenium) of human alcoholics: a proteomics study. Neurochem. Int. 50 (2007) 450-459
69. Khidekel N., Ficarro S.B., Clark P.M., Bryan M.C., Swaney D.L., Rexach J.E., Sun Y.E., Coon J.J., Peters E.C., and Hsieh-Wilson L.C. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. Nat. Chem. Biol. 3 (2007) 339-348
70. Krapfenbauer K., Fountoulakis M., and Lubec G. A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractions. Electrophoresis 24 (2003) 1847-1870
71. Kruger M., Kratchmarova I., Blagoev B., Tseng Y.H., Kahn C.R., and Mann M. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 2451-2456
72. Kuntz K.L., Twining R.C., Baldwin A.E., Vrana K.E., and Grigson P.S. Heroin self-administration: I. Incubation of goal-directed behavior in rats. Pharmacol. Biochem. Behav. 90 (2008) 344-348
73. Kuzmin A., and Johansson B. Expression of c-fos, NGFI-A and secretogranin II mRNA in brain regions during initiation of cocaine self-administration in mice. Eur. J. Neurosci. 11 (1999) 3694-3700
74. Lan W., Guhaniyogi J., Horn M.J., Xia J.Q., and Graham B. A density-based proteomics sample fractionation technology: folate deficiency induced oxidative stress response in liver and brain. J. Biomol. Tech. 18 (2007) 213-225
75. Layfield R., Tooth D., Landon M., Dawson S., Mayer J., and Alban A. Purification of poly-ubiquitinated proteins by S5a-affinity chromatography. Proteomics 1 (2001) 773-777
76. Lehrmann E., Afanador Z.R., ep-Soboslay A., Gallegos G., Darwin W.D., Lowe R.H., Barnes A.J., Huestis M.A., Cadet J.L., Herman M.M., Hyde T.M., Kleinman J.E., and Freed W.J. Postmortem diagnosis and toxicological validation of illicit substance use. Addict. Biol. 13 (2008) 105-117
77. Li C.Y., Mao X., and Wei L. Genes and (common) pathways underlying drug addiction. PLoS Comput. Biol. 4 (2008) e2
78. Li K.W., Jimenez C.R., van der Schors R.C., Hornshaw M.P., Schoffelmeer A.N., and Smit A.B. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 6 (2006) 2003-2008
79. Liao L., Cheng D., Wang J., Duong D.M., Losik T.G., Gearing M., Rees H.D., Lah J.J., Levey A.I., and Peng J. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J. Biol. Chem. 279 (2004) 37061-37068
80. Lull M.E., Erwin M., Morgan D., Roberts D.C., Vrana K.E., and Freeman W.M. Persistent proteomic alterations in the medial prefrontal cortex with abstinence from cocaine self-administration. Proteomics Clin. Appl. 3 (2009) 462-472
81. Lull M.E., Freeman W.M., Vrana K.E., and Mash D.C. Correlating human and animal studies of cocaine abuse and gene expression. Ann. N.Y. Acad. Sci. 1141 (2008) 58-75
82. Mark G.P., Hajnal A., Kinney A.E., and Keys A.S. Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology (Berl) 143 (1999) 47-53
83. Martin B., Brenneman R., Becker K.G., Gucek M., Cole R.N., and Maudsley S. iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease. PLoS ONE 3 (2008) e2750
84. Matsuda-Matsumoto H., Iwazaki T., Kashem M.A., Harper C., and Matsumoto I. Differential protein expression profiles in the hippocampus of human alcoholics. Neurochem. Int. 51 (2007) 370-376
85. Meany D.L., Xie H., Thompson L.V., Arriaga E.A., and Griffin T.J. Identification of carbonylated proteins from enriched rat skeletal muscle mitochondria using affinity chromatography-stable isotope labeling and tandem mass spectrometry. Proteomics 7 (2007) 1150-1163
86. Miserendino M.J., and Nestler E.J. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res. 674 (1995) 299-306
87. Monzo A., Bonn G.K., and Guttman A. Boronic acid-lectin affinity chromatography. 1. Simultaneous glycoprotein binding with selective or combined elution. Anal. Bioanal. Chem. 389 (2007) 2097-2102
88. Morelle W., and Michalski J.C. Glycomics and mass spectrometry. Curr. Pharm. Des. 11 (2005) 2615-2645
89. Morgan D., Brebner K., Lynch W.J., and Roberts D.C. Increases in the reinforcing efficacy of cocaine after particular histories of reinforcement. Behav. Pharmacol. 13 (2002) 389-396
90. Morgan D., and Roberts D.C. Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration. Neurosci. Biobehav. Rev. 27 (2004) 803-812
91. Moron J.A., Abul-Husn N.S., Rozenfeld R., Dolios G., Wang R., and Devi L.A. Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol. Cell. Proteomics 6 (2007) 29-42
92. Mouledous L., Hunt S., Harcourt R., Harry J., Williams K.L., and Gutstein H.B. Navigated laser capture microdissection as an alternative to direct histological staining for proteomic analysis of brain samples. Proteomics 3 (2003) 610-615
93. Mouledous L., Hunt S., Harcourt R., Harry J.L., Williams K.L., and Gutstein H.B. Proteomic analysis of immunostained, laser-capture microdissected brain samples. Electrophoresis 24 (2003) 296-302
94. Mueller L.N., Brusniak M.Y., Mani D.R., and Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J. Proteome Res. 7 (2008) 51-61
95. Mutschler N.H., Miczek K.A., and Hammer Jr. R.P. Reduction of zif268 messenger RNA expression during prolonged withdrawal following "binge" cocaine self-administration in rats. Neuroscience 100 (2000) 531-538
96. Nan Y., Yang S., Tian Y., Zhang W., Zhou B., Bu L., and Huo S. Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy. Med. Oncol. 26 (2008) 215-221
97. Nelson P.G., Kuddo T., Song E.Y., Dambrosia J.M., Kohler S., Satyanarayana G., Vandunk C., Grether J.K., and Nelson K.B. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int. J. Dev. Neurosci. 24 (2006) 73-80
98. Nie L., Wu G., Culley D.E., Scholten J.C., and Zhang W. Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications. Crit. Rev. Biotechnol. 27 (2007) 63-75
99. Nielsen P.A., Olsen J.V., Podtelejnikov A.V., Andersen J.R., Mann M., and Wisniewski J.R. Proteomic mapping of brain plasma membrane proteins. Mol. Cell. Proteomics 4 (2005) 402-408
100. O'Brien C.P. A range of research-based pharmacotherapies for addiction. Science 278 (1997) 66-70
101. O'Callaghan J.P., and Sriram K. Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins. J. Neurosci. Methods 135 (2004) 159-168
102. Olsen J.V., and Mann M. Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13417-13422
103. Olsen J.V., Nielsen P.A., Andersen J.R., Mann M., and Wisniewski J.R. Quantitative proteomic profiling of membrane proteins from the mouse brain cortex, hippocampus, and cerebellum using the HysTag reagent: mapping of neurotransmitter receptors and ion channels. Brain Res. 1134 (2007) 95-106
104. Pawlyk A.C., Ferber M., Shah A., Pack A.I., and Naidoo N. Proteomic analysis of the effects and interactions of sleep deprivation and aging in mouse cerebral cortex. J. Neurochem. 103 (2007) 2301-2313
105. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 5th Edn (2005), Academic Press, Burlington, MA
106. Phillips W.H., Ota K., and Wade N.A. Tandem mass spectrometry (MS/MS) utilizing electron impact ionization and multiple reaction monitoring for the rapid, sensitive, and specific identification and quantitation of morphine in whole blood. J. Anal. Toxicol. 13 (1989) 268-273
107. Pinaud R., Osorio C., Alzate O., and Jarvis E.D. Profiling of experience-regulated proteins in the songbird auditory forebrain using quantitative proteomics. Eur. J. Neurosci. 27 (2008) 1409-1422
108. Prokai L., Zharikova A.D., and Stevens Jr. S.M. Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J. Mass Spectrom. 40 (2005) 169-175
109. Qi M.L., Tagawa K., Enokido Y., Yoshimura N., Wada Y., Watase K., Ishiura S., Kanazawa I., Botas J., Saitoe M., Wanker E.E., and Okazawa H. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat. Cell. Biol. 9 (2007) 402-414
110. Qin Y., Ouyang Q., Pablo J., and Mash D.C. Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport 16 (2005) 1489-1493
111. Roberts D.C., Morgan D., and Liu Y. How to make a rat addicted to cocaine. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 1614-1624
112. Robin X., Hoogland C., Appel R.D., and Lisacek F. MIAPEGelDB, a web-based submission tool and public repository for MIAPE gel electrophoresis documents. J. Proteomics 71 (2008) 249-251
113. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 suppl. 1 (2004) 33-46
114. Rodd Z.A., Kimpel M.W., Edenberg H.J., Bell R.L., Strother W.N., McClintick J.N., Carr L.G., Liang T., and McBride W.J. Differential gene expression in the nucleus accumbens with ethanol self-administration in inbred alcohol-preferring rats. Pharmacol. Biochem. Behav. 89 (2008) 481-498
115. Rubakhin S.S., and Sweedler J.V. Characterizing peptides in individual mammalian cells using mass spectrometry. Nat. Protoc. 2 (2007) 1987-1997
116. Rubakhin S.S., and Sweedler J.V. Quantitative measurements of cell-cell signaling peptides with single-cell MALDI MS. Anal. Chem. 80 (2008) 7128-7136
117. Salim K., Guest P.C., Skynner H.A., Bilsland J.G., Bonnert T.P., McAllister G., and Munoz-Sanjuan I. Identification of proteomic changes during differentiation of adult mouse subventricular zone progenitor cells. Stem Cells Dev. 16 (2007) 143-165
118. Schindler J., Lewandrowski U., Sickmann A., Friauf E., and Nothwang H.G. Proteomic analysis of brain plasma membranes isolated by affinity two-phase partitioning. Mol. Cell. Proteomics 5 (2006) 390-400
119. Schoenbaum G., Saddoris M.P., Ramus S.J., Shaham Y., and Setlow B. Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions. Eur. J. Neurosci. 19 (2004) 1997-2002
120. Self D.W., McClenahan A.W., Beitner-Johnson D., Terwilliger R.Z., and Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21 (1995) 312-318
121. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de L.F., Kawasaki E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.C., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., Amur S., Bao W., Barbacioru C.C., Lucas A.B., Bertholet V., Boysen C., Bromley B., Brown D., Brunner A., Canales R., Cao X.M., Cebula T.A., Chen J.J., Cheng J., Chu T.M., Chudin E., Corson J., Corton J.C., Croner L.J., Davies C., Davison T.S., Delenstarr G., Deng X., Dorris D., Eklund A.C., Fan X.H., Fang H., Fulmer-Smentek S., Fuscoe J.C., Gallagher K., Ge W., Guo L., Guo X., Hager J., Haje P.K., Han J., Han T., Harbottle H.C., Harris S.C., Hatchwell E., Hauser C.A., Hester S., Hong H., Hurban P., Jackson S.A., Ji H., Knight C.R., Kuo W.P., LeClerc J.E., Levy S., Li Q.Z., Liu C., Liu Y., Lombardi M.J., Ma Y., Magnuson S.R., Maqsodi B., McDaniel T., Mei N., Myklebost O., Ning B., Novoradovskaya N., Orr M.S., Osborn T.W., Papallo A., Patterson T.A., Perkins R.G., Peters E.H., Peterson R., Philips K.L., Pine P.S., Pusztai L., Qian F., Ren H., Rosen M., Rosenzweig B.A., Samaha R.R., Schena M., Schroth G.P., Shchegrova S., Smith D.D., Staedtler F., Su Z., Sun H., Szallasi Z., Tezak Z., Thierry-Mieg D., Thompson K.L., Tikhonova I., Turpaz Y., Vallanat B., Van C., Walker S.J., Wang S.J., Wang Y., Wolfinger R., Wong A., Wu J., Xiao C., Xie Q., Xu J., Yang W., Zhang L., Zhong S., Zong Y., and Slikker Jr. W. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24 (2006) 1151-1161
122. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
123. Skold K., Svensson M., Norrman M., Sjogren B., Svenningsson P., and Andren P.E. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics 7 (2007) 4445-4456
124. Sleat D.E., Ding L., Wang S., Zhao C., Wang Y., Xin W., Zheng H., Moore D.F., Sims K.B., and Lobel P. Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology. Mol. Cell. Proteomics (2009)
125. Stefanski R., Ladenheim B., Lee S.H., Cadet J.L., and Goldberg S.R. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur. J. Pharmacol. 371 (1999) 123-135
126. Stevens S.M., Duncan R.S., Koulen P., and Prokai L. Proteomic analysis of mouse brain microsomes: identification and bioinformatic characterization of endoplasmic reticulum proteins in the mammalian central nervous system. J. Proteome Res. 7 (2008) 1046-1054
127. Sutton M.A., Schmidt E.F., Choi K.H., Schad C.A., Whisler K., Simmons D., Karanian D.A., Monteggia L.M., Neve R.L., and Self D.W. Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 421 (2003) 70-75
128. Svensson M., Boren M., Skold K., Falth M., Sjogren B., Andersson M., Svenningsson P., and Andren P.E. Heat stabilization of the tissue proteome: a new technology for improved proteomics. J. Proteome Res. 8 (2009) 974-981
129. Tannu N., Mash D.C., and Hemby S.E. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol. Psychiatry 12 (2007) 55-73
130. Tannu N.S., Howell L.L., and Hemby S.E. Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration. Mol. Psychiatry (2008) (Epub ahead of print)
131. Taylor C.F., Paton N.W., Lilley K.S., Binz P.A., Julian Jr. R.K., Jones A.R., Zhu W., Apweiler R., Aebersold R., Deutsch E.W., Dunn M.J., Heck A.J., Leitner A., Macht M., Mann M., Martens L., Neubert T.A., Patterson S.D., Ping P., Seymour S.L., Souda P., Tsugita A., Vandekerckhove J., Vondriska T.M., Whitelegge J.P., Wilkins M.R., Xenarios I., Yates III J.R., and Hermjakob H. The minimum information about a proteomics experiment (MIAPE). Nat. Biotechnol. 25 (2007) 887-893
132. Thomas K.L., Arroyo M., and Everitt B.J. Induction of the learning and plasticity-associated gene Zif268 following exposure to a discrete cocaine-associated stimulus. Eur. J. Neurosci. 17 (2003) 1964-1972
133. Thomas P.D., Campbell M.J., Kejariwal A., Mi H., Karlak B., Daverman R., Diemer K., Muruganujan A., and Narechania A. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 13 (2003) 2129-2141
134. Trujillo K.A., Kubota K.S., and Warmoth K.P. Continuous administration of opioids produces locomotor sensitization. Pharmacol. Biochem. Behav. 79 (2004) 661-669
135. Uhlen M., and Hober S. Generation and validation of affinity reagents on a proteome-wide level. J. Mol. Recognit. 22 (2009) 57-64
136. VanGuilder H.D., Vrana K.E., and Freeman W.M. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44 (2008) 619-626
137. Vignali D.A. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 243 (2000) 243-255
138. Wachtel S.R., and DeWit H. Subjective and behavioral effects of repeated d-amphetamine in humans. Behav. Pharmacol. 10 (1999) 271-281
139. Whiteaker J.R., Zhang H., Zhao L., Wang P., Kelly-Spratt K.S., Ivey R.G., Piening B.D., Feng L.C., Kasarda E., Gurley K.E., Eng J.K., Chodosh L.A., Kemp C.J., McIntosh M.W., and Paulovich A.G. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J. Proteome Res. 6 (2007) 3962-3975
140. Williams K., Wu T., Colangelo C., and Nairn A.C. Recent advances in neuroproteomics and potential application to studies of drug addiction. Neuropharmacology 47 suppl. 1 (2004) 148-166
141. Yang M.H., Jung M.S., Lee M.J., Yoo K.H., Yook Y.J., Park E.Y., Choi S.H., Suh Y.J., Kim K.W., and Park J.H. Gene expression profiling of the rewarding effect caused by methamphetamine in the mesolimbic dopamine system. Mol. Cells 26 (2008) 121-130
142. Zhong W., Dong Z., Tian M., Cao J., Xu T., Xu L., and Luo J. Opiate withdrawal induces dynamic expressions of AMPA receptors and its regulatory molecule CaMKIIalpha in hippocampal synapses. Life Sci. 79 (2006) 861-869
143. Zichi D., Eaton B., Singer B., and Gold L. Proteomics and diagnostics: let's get specific, again. Curr. Opin. Chem. Biol. 12 (2008) 78-85